Overview
Brookdale Q3 adjusted EBITDA grows 20.4% yr/yr, beating analyst expectations
Net loss in Q3 widens to $114.7 mln due to non-cash impairment charges
Company raises full-year adjusted EBITDA guidance to $455-460 mln
Outlook
Brookdale raises 2025 Adjusted EBITDA guidance to $455 mln - $460 mln
Company expects 2025 RevPAR growth of 5.25% to 6.00%
Brookdale anticipates 2025 Adjusted Free Cash Flow of $30 mln to $50 mln
Result Drivers
OCCUPANCY INCREASE - Co reports highest occupancy since pandemic onset, driven by suppressed inventory growth and rising demand
RESIDENT FEES - Increase in resident fees attributed to higher occupancy and annual rate increase, offset by community dispositions
ADJUSTED EBITDA GROWTH - Growth driven by increased resident fees and reduced lease payments, offset by higher operating expenses
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Net Income
-$114.70 mln
Q3 Adjusted EBITDA
Beat
$111.10 mln
$106.13 mln (3 Analysts)
Q3 RevPAR
$5,160
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy", 1 "hold" and 2 "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy."
Wall Street's median 12-month price target for Brookdale Senior Living Inc is $8.00, about 15.9% below its November 5 closing price of $9.27
Press Release: ID:nPn4wfYv2a
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)